BMP2-Induced inflammation can be suppressed by the osteoinductive growth factor NELL-1

Tissue Engineering - Part A

Volumn 19, Issue 21-22, 2013, Pages 2390-2401

  Shen, Jia ^a   James, Aaron W ^a,b   Zara, Janette N ^a   Asatrian, Greg ^a   Khadarian, Kevork ^a   Zhang, James B ^a   Ho, Stephanie ^a   Kim, Hyun Ju ^a   Ting, Kang ^a   Soo, Chia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; BONE; CELL CULTURE; POLYMERASE CHAIN REACTION; PROTEINS; REPAIR;

ANTI-INFLAMMATORY EFFECTS; CLINICAL COMPLICATIONS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY RESPONSE; MOUSE EMBRYONIC FIBROBLASTS; REACTIVE OXYGEN SPECIES; SYSTEMIC INFLAMMATION; TRANSCRIPTIONAL ACTIVITY;

PATHOLOGY;

ANTIINFLAMMATORY AGENT; BONE MORPHOGENETIC PROTEIN 2; GROWTH FACTOR; GROWTH FACTOR NEL-LIKE MOLECULE 1; I KAPPA B; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; BONE GRAFT; BONE REGENERATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO CELL; FIBROBLAST; MALE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MICE; NERVE TISSUE PROTEINS; NIH 3T3 CELLS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887085623     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0519     Document Type: Conference Paper

References (65)

1. Carlisle, E., and Fischgrund, J.S. Bone morphogenetic proteins for spinal fusion. Spine J 5, 240S, 2005
2. McKay, B., and Sandhu, H.S. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine (Phila Pa 1976) 27, S66, 2002
3. Gupta, M.C., and Khan, S.N. Application of bone morphogenetic proteins in spinal fusion. Cytokine Growth Factor Rev 16, 347, 2005
4. Lissenberg-Thunnissen, S.N., de Gorter, D.J., Sier, C.F., and Schipper, I.B. Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35, 1271, 2011
5. Garrison, K.R., Shemilt, I., Donell, S., Ryder, J.J., Mugford, M., Harvey, I., et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev CD006950, 2010
6. Dimar, J.R., Glassman, S.D., Burkus, K.J., and Carreon, L.Y. Clinical outcomes and fusion success at 2 years of singlelevel instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976) 31, 2534; discussion 40, 2006
7. Benglis, D., Wang, M.Y., and Levi, A.D. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 62, ONS423, 2008
8. Wong, D.A., Kumar, A., Jatana, S., Ghiselli, G., and Wong, K. Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 8, 1011, 2008
9. Joseph, V., and Rampersaud, Y.R. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: A CT analysis. Spine (Phila Pa 1976) 32, 2885, 2007
10. Shah, R.K., Moncayo, V.M., Smitson, R.D., Pierre-Jerome, C., and Terk, M.R. Recombinant human bone morphogenetic protein 2-induced heterotopic ossification of the retroperitoneum, psoas muscle, pelvis and abdominal wall following lumbar spinal fusion. Skeletal Radiol 39, 501, 2010
11. Boraiah, S., Paul, O., Hawkes, D., Wickham, M., and Lorich, D.G. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: A preliminary report. Clin Orthop Relat Res 467, 3257, 2009
12. Chen, N.F., Smith, Z.A., Stiner, E., Armin, S., Sheikh, H., and Khoo, L.T. Symptomatic ectopic bone formation after offlabel use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. J Neurosurg Spine 12, 40, 2010
13. Lewandrowski, K.U., Nanson, C., and Calderon, R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: A report of five cases. Spine J 7, 609, 2007
14. Vaidya, R., Sethi, A., Bartol, S., Jacobson, M., Coe, C., and Craig, J.G. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 21, 557, 2008
15. Balseiro, S., and Nottmeier, E.W. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases. Spine J 10, e6, 2010
16. Mannion, R.J., Nowitzke, A.M., and Wood, M.J. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2-but what is the cost? Spine J 11, 527, 2011
17. Carter, T.G., Brar, P.S., Tolas, A., and Beirne, O.R. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg 66, 1417, 2008
18. Mindea, S.A., Shih, P., and Song, J.K. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: A series review. Spine (Phila Pa 1976) 34, 1480; discussion 5, 2009
19. Robin, B.N., Chaput, C.D., Zeitouni, S., Rahm, M.D., Zerris, V.A., and Sampson, H.W. Cytokine-mediated inflammatory reaction following posterior cervical decompression and fusion associated with recombinant human bone morphogenetic protein-2: A case study. Spine (Phila Pa 1976) 35, E1350, 2010
20. Garrett, M.P., Kakarla, U.K., Porter, R.W., and Sonntag, V.K. Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions. Neurosurgery 66, 1044; discussion 9, 2010
21. MacDonald, K.M., Swanstrom, M.M., McCarthy, J.J., Nemeth, B.A., Guliani, T.A., and Noonan, K.J. Exaggerated inflammatory response after use of recombinant bone morphogenetic protein in recurrent unicameral bone cysts. J Pediatr Orthop 30, 199, 2010
22. Carragee, E.J., Hurwitz, E.L., and Weiner, B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J 11, 471, 2011
23. FDA. FDA Public Health Notification: Life-Threatening Complications Associated with Recombinant Human Bone Morphogenetic Protein in Cervical Spine Fusion. www.fda .gov/MedicalDevices/Safety/AlertsandNotices/PublicHealth Notifications/ucm062000.htm, 2008
24. Owens, K., Glassman, S.D., Howard, J.M., Djurasovic, M., Witten, J.L., and Carreon, L.Y. Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion. Eur Spine J 20, 612, 2011
25. Tumialan, L.M., Pan, J., Rodts, G.E., and Mummaneni, P.V. The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: A review of 200 patients. J Neurosurg Spine 8, 529, 2008
26. Zara, J., Siu, R.K., Zhang, X., Shen, J., Ngo, R., Lee, M., et al. High doses of BMP2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 2011
27. Shields, L.B., Raque, G.H., Glassman, S.D., Campbell, M., Vitaz, T., Harpring, J., et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 31, 542, 2006
28. Lee, K.B., Murray, S.S., Taghavi, C.E., Song, K.J., Brochmann, E.J., Johnson, J.S., et al. Bone morphogenetic proteinbinding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-Tissue inflammation. Spine J 11, 568, 2011
29. Helbing, T., Rothweiler, R., Ketterer, E., Goetz, L., Heinke, J., Grundmann, S., et al. BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood 118, 5040, 2011
30. Akeel, S., El-Awady, A., Hussein, K., El-Refaey, M., Elsalanty, M., Sharawy, M., et al. Recombinant bone morphogenetic protein-2 induces up-regulation of vascular endothelial growth factor and interleukin 6 in human preosteoblasts: Role of reactive oxygen species. Arch Oral Biol 57, 445, 2012
31. Cunningham, N.S., Paralkar, V., and Reddi, A.H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A 89, 11740, 1992
32. Lu, S.S., Zhang, X., Soo, C., Hsu, T., Napoli, A., Aghaloo, T., et al. The osteoinductive properties of Nell-1 in a rat spinal fusion model. Spine J 7, 50, 2007
33. Aghaloo, T., Cowan, C.M., Chou, Y.F., Zhang, X., Lee, H., Miao, S., et al. Nell-1-induced bone regeneration in calvarial defects. Am J Pathol 169, 903, 2006
34. Aghaloo, T., Jiang, X., Soo, C., Zhang, Z., Zhang, X., Hu, J., et al. A study of the role of nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation. Mol Ther 15, 1872, 2007
35. Zhang, X., Peault, B., Chen, W., Li, W., Corselli, M., James, A.W., et al. The Nell-1 growth factor stimulates bone formation by purified human perivascular cells. Tissue Eng Part A 17, 2497, 2011
36. Li, W., Zara, J.N., Siu, R.K., Lee, M., Aghaloo, T., Zhang, X., et al. Nell-1 enhances bone regeneration in a rat critical-sized femoral segmental defect model. Plast Reconstr Surg 127, 580, 2011
37. James, A.W., Pan, A., Chiang, M., Zara, J.N., Zhang, X., Ting, K., et al. A new function of Nell-1 protein in repressing adipogenic differentiation. Biochem Biophys Res Commun 411, 126, 2011
38. Li, W., Lee, M., Whang, J., Siu, R.K., Zhang, X., Liu, C., et al. Delivery of lyophilized Nell-1 in a rat spinal fusion model. Tissue Eng Part A 16, 2861, 2010
39. Siu, R.K., Lu, S.S., Li, W., Whang, J., McNeill, G., Zhang, X., et al. Nell-1 protein promotes bone formation in a sheep spinal fusion model. Tissue Eng Part A 17, 1123, 2011
40. Siu, R.K., Zara, J.N., Hou, Y., James, A.W., Kwak, J., Zhang, X., et al. NELL-1 promotes cartilage regeneration in an in vivo rabbit model. Tissue Eng Part A 18, 252, 2012
41. Zhang, X., Ting, K., Bessette, C.M., Culiat, C.T., Sung, S.J., Lee, H., et al. Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2( + / -) mice. J Bone Miner Res 26, 777, 2011
42. Bokui, N., Otani, T., Igarashi, K., Kaku, J., Oda, M., Nagaoka, T., et al. Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation. FEBS Lett 582, 365, 2008
43. Cowan, C.M., Jiang, X., Hsu, T., Soo, C., Zhang, B., Wang, J.Z., et al. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts. J Bone Miner Res 22, 918, 2007
44. Aghaloo, T., Cowan, C.M., Zhang, X., Freymiller, E., Soo, C., Wu, B., et al. The effect of NELL1 and bone morphogenetic protein-2 on calvarial bone regeneration. J Oral Maxillofac Surg 68, 300, 2010
45. Xia, L., Xu, Y., Chang, Q., Sun, X., Zeng, D., Zhang, W., et al. Maxillary sinus floor elevation using BMP-2 and Nell-1 gene-modified bone marrow stromal cells and TCP in rabbits. Calcif Tissue Int 89, 53, 2011
46. Allen, A., and Southern, S. A novel technique of computerassisted image analysis to quantify molecular stress in cetaceans. www.mediacy.com/pdfs/ 021209cetaceans.pdf, 2002
47. Chen, W., Zhang, X., Siu, R.K., Chen, F., Shen, J., Zara, J.N., et al. Nfatc2 is a primary response gene of nell-1 regulating chondrogenesis in ATDC5 cells. J Bone Miner Res 26, 1230, 2011
48. Zara, J.N., Siu, R.K., Zhang, X., Shen, J., Ngo, R., Lee, M., et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 17, 1389, 2011
49. Li, Q., and Verma, I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2, 725, 2002
50. Yeler, H., Tahtabas, F., and Candan, F. Investigation of oxidative stress during fracture healing in the rats. Cell Biochem Funct 23, 137, 2005
51. Smucker, J.D., Rhee, J.M., Singh, K., Yoon, S.T., and Heller, J.G. Increased swelling complications associated with offlabel usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976) 31, 2813, 2006
52. Perri, B., Cooper, M., Lauryssen, C., and Anand, N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: A case study. Spine J 7, 235, 2007
53. Yaremchuk, K., Toma, M., and Somers, M. Acute airway obstruction associated with the use of bone-morphogenetic protein in cervical spinal fusion. Laryngoscope 120 Suppl 4, S140, 2010
54. Vaidya, R., Carp, J., Sethi, A., Bartol, S., Craig, J., and Les, C.M. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16, 1257, 2007
55. Baskin, D.S., Ryan, P., Sonntag, V., Westmark, R., and Widmayer, M.A. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine (Phila Pa 1976) 28, 1219; discussion 25, 2003
56. Stachniak, J.B., Diebner, J.D., Brunk, E.S., and Speed, S.M. Analysis of prevertebral soft-Tissue swelling and dysphagia in multilevel anterior cervical discectomy and fusion with recombinant human bone morphogenetic protein-2 in patients at risk for pseudarthrosis. J Neurosurg Spine 14, 244, 2011
57. Patel, V.V., Zhao, L., Wong, P., Pradhan, B.B., Bae, H.W., Kanim, L., et al. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. Spine J 6, 397; discussion 4, 2006
58. Dickerman, R.D., Reynolds, A.S., Morgan, B.C., Tompkins, J., Cattorini, J., and Bennett, M. rh-BMP-2 can be used safely in the cervical spine: Dose and containment are the keys! Spine J 7, 508, 2007
59. Boakye, M., Mummaneni, P.V., Garrett, M., Rodts, G., and Haid, R. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2, 521, 2005
60. Tan, Y., Montgomery, S.R., Aghdasi, B.G., Inoue,H., Kaner, T., Tian, H., et al. The effect of corticosteroid administration on soft tissue inflammation associated with rhBMP-2 use in a rodent model of inflammation. Spine (Phila Pa 1976) 8, 806 2013
61. Ratanavaraporn, J., Furuya, H., and Tabata, Y. Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration. Biomaterials 33, 304, 2012
62. Iyer, S.S., Accardi, C.J., Ziegler, T.R., Blanco, R.A., Ritzenthaler, J.D., Rojas, M., et al. Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS One 4, e5017, 2009
63. James, A.W., Pang, S., Askarinam, A., Corselli, M., Zara, J.N., Goyal, R., et al. Additive effects of sonic hedgehog and nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells. Stem Cells Dev 21, 2170, 2012
64. Kang, Q., Song, W.X., Luo, Q., Tang, N., Luo, J., Luo, X., et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 18, 545, 2009
65. Sottile, V., and Seuwen, K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 475, 201, 2000